Nothing Special   »   [go: up one dir, main page]

RU94022543A - Medicinal agent base and a method of its preparing - Google Patents

Medicinal agent base and a method of its preparing

Info

Publication number
RU94022543A
RU94022543A RU94022543/14A RU94022543A RU94022543A RU 94022543 A RU94022543 A RU 94022543A RU 94022543/14 A RU94022543/14 A RU 94022543/14A RU 94022543 A RU94022543 A RU 94022543A RU 94022543 A RU94022543 A RU 94022543A
Authority
RU
Russia
Prior art keywords
particles
effect
placental material
therapeutic effect
prepared
Prior art date
Application number
RU94022543/14A
Other languages
Russian (ru)
Inventor
Ю.Е. Беляев
В.А. Власов
Original Assignee
АОЗТ "Научно-практический центр медикобиологических проблем"
АО "Кормист"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АОЗТ "Научно-практический центр медикобиологических проблем", АО "Кормист" filed Critical АОЗТ "Научно-практический центр медикобиологических проблем"
Priority to RU94022543/14A priority Critical patent/RU94022543A/en
Priority to PCT/RU1995/000125 priority patent/WO1995034310A1/en
Publication of RU94022543A publication Critical patent/RU94022543A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: medicine, therapy, pharmacy. SUBSTANCE: invention is employed as initial component for medicinal agents preparing for different purposes showing therapeutic effect. The base of medicinal agent is placental material as solid particles. Placental material is prepared in the form of solid powder-like particles showing developed porous structure. The state and pore content and bioactive substances were given in variants. Proposed base shows properties of the natural ion-exchange resin - from trace elements to the large protein structures. Also, particles acting as concentrating agent of bioactive substances can be prepared. EFFECT: prolonged therapeutic and biological effect on organism.

Claims (1)

Изобретение относится к медицине, конкретно к терапии, и может служить исходным компонентом для приготовления лекарственных средств различного назначения, обладающих терапевтическим эффектом. Предлагаемое техническое решение позволяет создать основу лекарственного средства, способную длительно сохранять свои биологически активные свойства и обладающую эффектом природного ионообменника биологических веществ широкого спектра действия от микроэлементов до крупных белковых структур. Кроме того, это техническое решение позволяет получить частицы, выполняющие функцию концентратора биологически активных веществ, что делает возможным пролонгированное терапевтическое воздействие на организм. Известна основа лекарственного средства и способ ее получения, содержащая плацентарный материал в виде твердых частиц. Новым является то, что плацентарный материал выполнен в виде твердых порошкообразных частиц, каждая из которых имеет развитую пористую структуру.The invention relates to medicine, specifically to therapy, and can serve as a starting component for the preparation of drugs for various purposes with a therapeutic effect. The proposed technical solution allows you to create the basis of a medicinal product that is able to preserve its biologically active properties for a long time and has the effect of a natural ion exchanger of biological substances with a wide spectrum of activity from trace elements to large protein structures. In addition, this technical solution allows to obtain particles that act as a concentrator of biologically active substances, which makes possible a prolonged therapeutic effect on the body. Known drug base and method for its preparation, containing placental material in the form of solid particles. New is that the placental material is made in the form of solid powder particles, each of which has a developed porous structure.
RU94022543/14A 1994-06-10 1994-06-10 Medicinal agent base and a method of its preparing RU94022543A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU94022543/14A RU94022543A (en) 1994-06-10 1994-06-10 Medicinal agent base and a method of its preparing
PCT/RU1995/000125 WO1995034310A1 (en) 1994-06-10 1995-06-09 Medicament base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94022543/14A RU94022543A (en) 1994-06-10 1994-06-10 Medicinal agent base and a method of its preparing

Publications (1)

Publication Number Publication Date
RU94022543A true RU94022543A (en) 1996-05-20

Family

ID=20157167

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94022543/14A RU94022543A (en) 1994-06-10 1994-06-10 Medicinal agent base and a method of its preparing

Country Status (2)

Country Link
RU (1) RU94022543A (en)
WO (1) WO1995034310A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22693A1 (en) * 1999-02-22 2001-07-31 Ct De Histoterapia Placentaria COMPOSITION FOR THE TREATMENT OF PSORIASIS AND METHOD FOR OBTAINING
US20090123560A1 (en) * 2005-09-16 2009-05-14 Kenji Yoshida Hematopoietic Stem Cell Proliferation Inducing Agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5221570B2 (en) * 1973-08-30 1977-06-11
DE2640387C3 (en) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Tissue-specific protein and method for its production
EP0302459A3 (en) * 1987-08-04 1990-02-07 Sumitomo Pharmaceuticals Company, Limited Human placenta-derived thermostable cell growth factor and a process for production thereof

Also Published As

Publication number Publication date
WO1995034310A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
EP0278074B1 (en) Apparatus for the endermic application of medicines
DE3680368D1 (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIE FACTOR, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS.
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
IS4083A (en) Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals
CA3020400A1 (en) Compositions for topical application of compounds
RU99118587A (en) A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, METHOD OF ITS PRODUCTION AND ITS APPLICATION
GEP20022804B (en) Erythropoietin Derivatives
PT740650E (en) CO-DRUGS AS A METHOD OF CONTROLLED DRUG ADMINISTRATION
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
ES2173641T3 (en) COMPOSITION OF OPIACE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES.
RU99118588A (en) A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING FORMOTEROL
RU95101385A (en) Products containing g-csf and tnf-binding protein
DK0460622T3 (en) Drug preparation for systemic treatment of ornamental and utility fish
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
RU99118586A (en) A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING TERBUTALINE SULFATE, METHOD FOR PRODUCING AND ITS APPLICATION
RU94022543A (en) Medicinal agent base and a method of its preparing
KR100466757B1 (en) Topical preparation for introducing peptidaceous pharmacons in living organisms
RU96102209A (en) MEDICINE
UA39179C2 (en) Pharmaceutical composition for treating disorders of heart rhythm in large mammalians and humans, method for its preparation and antiarrhythmic drug
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
RU94022194A (en) Medicinal agent base
RU94022192A (en) BASIS OF MEDICINE
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
CN105999276B (en) A kind of advanced composite material (ACM) and its preparation method and application for pharmaceutical carrier
RU19467U1 (en) DRUG BASED ON CYTOKINES